September is Gynecologic Cancer Awareness Month, an awareness campaign launched by the Foundation for Women’s Cancer.
This year the foundation is encouraging patients and advocates to share their knowledge and experiences using #IWishIKnew on social media.
To correspond with this campaign, HemOnc Today compiled eights stories for oncologists on screening recommendations, health disparities and treatment updates across gynecologic cancers.
The U.S. Preventive Services Task Force issued a recommendation statement and evidence review supporting cervical cancer screening via cervical cytology every 3 years among women aged 21 to 29 years. READ MORE.
In a HemOnc Today cover story, experts discussed increased endometrial cancer incidence and the need for more screening and research funding. READ MORE.
Women with physical and mental disabilities appeared significantly less likely to undergo cervical cancer screening. READ MORE.
Early detection strategies that focus on women with postmenopausal bleeding could catch as many as 90% of endometrial cancers. READ MORE.
Only 8% of older or disabled women with breast or ovarian cancer who had Medicare and met eligibility criteria underwent testing for BRCA1 and BRCA2 mutations between 2000 and 2014. READ MORE.
The Affordable Care Act’s dependent coverage mandate appeared to lead to earlier detection of gynecologic cancers among young women. READ MORE.
Patients who received pelvic chemoradiation for the treatment of newly diagnosed metastatic cervical cancer had improved survival compared with those who received chemotherapy alone. READ MORE.
HPV catch-up vaccination appeared effective in women aged up to 20 years. However, more research is needed to assess the effect in women aged 21 to 26 years. READ MORE.